Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Noninvasive Evaluation of CD20 Expression Using 64Cu-Labeled F(ab′)2 Fragments of Obinutuzumab in Lymphoma | Journal of Nuclear Medicine
anti-CD20 (Rituximab) - ACE Biolabs Antibody │ Chemical │ Enzyme
Novel CD20 monoclonal antibodies for lymphoma therapy | Journal of Hematology & Oncology | Full Text
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
SciELO - Brasil - CD20 role in pathophysiology of Hodgkin's disease CD20 role in pathophysiology of Hodgkin's disease
Frontiers | Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | SpringerLink
Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy | PNAS
A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies | SpringerLink
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Potential anti-CD20 mAb effector mechanisms. (A) Fc-Fc ␥ R–dependent... | Download Scientific Diagram
Comparison of commercially available anti-CD20 antibodies | Download Table
Ublituximab: A Novel Anti-CD20 Therapy for Multiple Sclerosis - touchNEUROLOGY
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
Unraveling the T–B tangle in anti-CD20 multiple sclerosis therapy | PNAS
CD20 - Wikipedia
Combining schematic of different effector mechanisms of anti CD20 mAbs... | Download Scientific Diagram
Three Anti-CD20 Antibodies: Rituximab, Ocrelizumab, and Ofatumumab.... | Download Scientific Diagram
Anti-CD20 monoclonal antibody - List of Frontiers' open access articles
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
